NDC product
risedronate sodium
NDC 0591-2075 · Actavis Pharma, Inc.
Key facts
| Product NDC | 0591-2075 |
|---|---|
| Proprietary name | risedronate sodium |
| Labeler | Actavis Pharma, Inc. |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA020835 |
| Marketing start | Jun 27, 2014 |
| Marketing end | May 31, 2021 |
| Listing certified through | May 31, 2021 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: